Nina Lukinova, Ph.D.

Program Director

Prior to joining NCI in 2016, Dr. Nina Lukinova has served as Associate Director in a private biotech company holding responsibilities in product development for clinical diagnostics. She led a CLIA-certified contract service laboratory where she developed and validated various assays for drug monitoring and measuring levels of biomarkers/infections in blood specimens. Her Ph.D. thesis on early mechanisms of blood coagulation included clinical assay development to detect pathologies in blood clotting and fibrinolysis. After completing postdoctoral training in molecular genetics at The University of Pennsylvania she transitioned to biotech industry with the focus on clinical assay development under different platforms and technologies. With her diversified scientific expertise, she has served as a scientific consultant in assay development for several biotech companies.